|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 656.01 USD | +0.63% |
|
-3.06% | -15.01% |
| 07-24 | US FDA approves Outlook Therapeutics' eye disease drug | RE |
| 07-24 | Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 66.74B | |||||
| 53.32B | |||||
| 48.12B | |||||
| 38.25B | - | ||||
| 29.85B | |||||
| 23.51B |
Select your edition
All financial news and data tailored to specific country editions
